The global NT growth factor receptor market is anticipated to grow at a considerable CAGR during the forecast period (2022-2028). The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, new product launches, FDA approval, research, and development of new drugs to stay competitive in the market. For instance, in May 2021, FDA grants approval to amivantamab-vmjw, which is a bi-specific antibody directed against epidermal growth factor and MET receptors, for adult patients with locally advanced or metastatic non-small cell lung cancer with epidermal growth factor receptors.
Browse the full report description “Global NT Growth Factor Receptor Market Size, Share & Trends Analysis Report By Type (AZD-7451, Larotrectinib, DS-6051, LM-22B10, and Others), and By Application (Breast Cancer, Brain Cancer, Solid Tumor, Colon Cancer, Fibrosarcoma, and Others) Forecast 2022-2028” at https://www.omrglobal.com/industry-reports/nt-growth-factor-receptor-market
Moreover, in May 2020, FDA approved selpercatinib, to treat adult patients with metastatic RET fusion-positive non-small cell lung cancer. in May 2020, FDA also approved Pemazyre as the drug to treat adults with locally advanced, previously treated, advanced cholangiocarcinoma with tumors containing a fusion or other rearrangement of the fibroblast growth factor receptor 2 gene. In November 2018, FDA approved larotrectinib for the treatment of adult and pediatric patients with solid tumors that have an NTRK gene fusion without a known acquired resistance mutation.
Market Coverage
Segment Covered-
Regions Covered-
Competitive Landscape - AstraZeneca, Daiichi Sankyo Co. Ltd., HANDOK Inc., Ignyta Inc., Loxo Oncology, and others.
Key questions addressed by the report
What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
Global NT Growth Factor Receptor Market Report Segment
By Type
By Application
Global NT Growth Factor Receptor Market Report Segment by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/nt-growth-factor-receptor-market